Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in NURIX THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 157,350 shares of NRIX (NURIX THERAPEUTICS INC), worth $2.4M as of 2026-Q1. The position was decreased (-6.8% shares). NRIX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.4M
Current Shares
157,350
Total Value Change
-$246,438
Total Shares Change
+28,679
Other major holders of NRIX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, BlackRock, Inc., BlackRock Finance, Inc.
Decreased |
| 157,350 |
-6.8% |
| $2.4M |
| 0.0% |
| $15.81 |
0 |
| 2025-Q4 | Increased | 168,843 | +72.0% | $3.2M | 0.0% | $19.02 | 40 |
| 2025-Q3 | Decreased | 98,145 | -57.7% | $906,860 | 0.0% | $9.28 | 0 |
| 2025-Q2 | Increased | 232,055 | +45.5% | $2.6M | 0.0% | $11.64 | 36 |
| 2025-Q1 | Increased | 159,530 | +8.7% | $1.9M | 0.0% | $12.15 | 28 |
| 2024-Q4 | Increased | 146,713 | +14.2% | $2.8M | 0.0% | $18.64 | 30 |
| 2024-Q3 | Decreased | 128,524 | -0.1% | $2.9M | 0.0% | $23.05 | 0 |
| 2024-Q2 | New | 128,671 | - | $2.7M | 0.0% | $20.87 | 36 |